524414 — Norris Medicines Balance Sheet
0.000.00%
- IN₹167.91m
- IN₹378.12m
- IN₹56.36m
- 20
- 10
- 69
- 21
Annual balance sheet for Norris Medicines, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6.58 | 13.2 | 7.22 | 5.84 | 7.48 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 27.6 | 17.9 | 10.9 | 11 | 10.6 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 74.4 | 82.3 | 42.7 | 49.2 | 61.4 |
Net Property, Plant And Equipment | 82.5 | 76.7 | 70.7 | 64.7 | 57.9 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 206 | 198 | 142 | 137 | 142 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 80.4 | 117 | 67.8 | 77 | 92.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 230 | 272 | 249 | 261 | 278 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -24.7 | -74.3 | -107 | -124 | -136 |
Total Liabilities & Shareholders' Equity | 206 | 198 | 142 | 137 | 142 |
Total Common Shares Outstanding |